4 Oral: Casdatifan in patients (pts) with previously treated clear cell renal cell cancer (ccRCC) and other solid tumors; preliminary results from ARC- 20: A phase 1, open-label dose-escalation and expansion study
Titel:
4 Oral: Casdatifan in patients (pts) with previously treated clear cell renal cell cancer (ccRCC) and other solid tumors; preliminary results from ARC- 20: A phase 1, open-label dose-escalation and expansion study
Auteur:
Choueiri, T. Garmezy, B. Park, S.H. Rha, S.Y. Lee, J.L. Foster, P. Negro, C. Chen, J. Nuyten, D.S.A. Patnaik, A.